IP Library Granted Patent US 9,315,560
Granted Patent B2
US 9,315,560 · App. 12/860,501 · Granted Apr 19, 2016

Purification of VWF for increased removal of non-lipid enveloped viruses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,560
App. No.
12/860,501
Granted
Apr 19, 2016
Kind
B2
Abstract

The present invention provides methods for purifying Von Willebrand factor (VWF) for increased removal of non-lipid enveloped viruses.

Claims (13)

1. A method for removing a non-lipid enveloped virus from a protein-containing solution comprising:

applying the protein-containing solution to a cation exchange resin at a pH of 1.6 pH units or more above the isoelectric point of a protein in the protein-containing solution; and

washing the cation exchange resin with a wash buffer to form an eluate, said wash buffer having a pH that is lower than the pH of the protein-containing solution applied to the cation exchange resin, wherein the protein has a molecular mass of at least about 150 kilodaltons, and whereby the non-lipid enveloped virus is removed from the protein-containing solution.

2. The method of claim 1 , wherein the solution applied to the cation exchange resin is at least 1.8 pH units above the isoelectric point of VWF.

3. The method of claim 1 , wherein the pH of the solution applied to the cation exchange resin is greater than 7.0.

4. The method of claim 1 , wherein the cation exchange resin has a negatively charged group selected from the group consisting of carboxymethyl (CM), sulfoalkyl, sulfated esters of cellulose, heparin and methylsulfonate (S).

5. The method of claim 4 , wherein the negatively charged sulfoalkyl group is sulfopropyl (SP) or sulfoethyl (SE).

6. The method of claim 1 , wherein the pH of the wash buffer is greater than the isoelectric point of the VWF applied to the cation exchange resin.

7. A method for removing a non-lipid enveloped virus from a VWF-containing solution comprising:

applying the solution to a cation exchange resin, wherein the pH of the solution is 2.0 pH units or more above the isoelectric point of VWF; and

washing the cation exchange resin with a wash buffer to form an eluate, said wash buffer having a pH that is equal to or lower than the pH of the solution applied to the cation exchange resin, and whereby the non-lipid enveloped virus is removed from the VWF-containing solution.

8. The method of claim 7 , wherein the pH of the VWF-containing solution and the wash buffer is about 9.0.

9. The method of claim 1 , wherein the VWF-containing solution applied to the cation exchange resin is at least 2.0 pH units above the isoelectric point of the VWF.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055188/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036373/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036376/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2010
From: MITTERER, ARTUR; HASSLACHER, MEINHARD; MAYER, CHRISTA
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 025555/0672 →